Science Explorer Back to mapMap
Discussion
Researcher · Cubist Pharmaceuticals (United States) · United States

Jeffrey D. Daubert

Jeffrey D. Daubert publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Physiology, on topics such as Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling and Pharmacological Receptor Mechanisms and Effects.

OpenAlex
World rank
#4,185,129
of 7,710,434 ranked researchers
Rank in United States
#1,130,988
of 1,627,098
Works
16
Citations
593
Citations per work
37.1
h-index
12
i10-index 12Top 65% in Molecular Biology
Jeffrey D. Daubert

What does Jeffrey D. Daubert research?

Jeffrey D. Daubert's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Neuroscience (27%), Medicine (21%).

Life Sciences: 11 works · 70.9% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 39.6% of their workMolecular Biology: 6 works · 39.6% of their workNeuroscience: 4 works · 27.1% of their workCellular and Molecular Neuroscience: 4 works · 27.1% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 4.2% of their workPharmacology: 1 works · 4.2% of their workHealth Sciences: 3 works · 20.9% of their workMedicine: 3 works · 20.9% of their workPhysiology: 2 works · 12.5% of their workSurgery: 1 works · 6.3% of their workAnesthesiology and Pain Medicine: 0 works · 2.1% of their workEverything else: 1 works · 8.2% of their workTHEIR WORKJeffrey D.Daubert16works
Life Sciences71%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology639.6%
    2. Neuroscience427.1%
    3. Pharmacology, Toxicology and Pharmaceutics14.2%
    1. Medicine320.9%
  3. Everything else18.2%
  1. 1Molecular Biology40% of their works
  2. 2Cellular and Molecular Neuroscience27% of their works
  3. 3Physiology12% of their works
  4. 4Surgery6% of their works
  5. 5Pharmacology4% of their works
  6. 6Anesthesiology and Pain Medicine2% of their works

Research topics

Which keywords describe Jeffrey D. Daubert's research?

The keywords of their largest research topics: Neuropeptides, Receptors, Drug Discovery, Pharmacology, Crystal Structure, G-Protein-Coupled Receptors, Chronic Pain and Central Sensitization.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Neuropeptides131 topic
  2. Receptors131 topic
  3. Drug Discovery122 topics
  4. Pharmacology112 topics
  5. Crystal Structure101 topic
  6. G-Protein-Coupled Receptors101 topic
  7. Chronic Pain82 topics
  8. Central Sensitization61 topic
  9. Chaperone61 topic
  10. Neuropathic Pain61 topic
  11. Sigma-1 Receptor61 topic
  12. Foldamers21 topic
  13. Peptide Synthesis21 topic
  14. Postoperative Pain21 topic
  15. Regional Anesthesia21 topic
  16. Biological Activities11 topic
  17. Glycyrrhizin11 topic
  18. Licorice11 topic
  19. Phenothiazines11 topic

Where does Jeffrey D. Daubert work?

Jeffrey D. Daubert's main affiliation in the publication record is Cubist Pharmaceuticals (United States), United States.

How many publications and citations does Jeffrey D. Daubert have?

OpenAlex counts 16 works and 593 citations for Jeffrey D. Daubert, an h-index of 12, ranking #4,185,129 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeffrey D. Daubert. Posts are plain text and can be reported.